Voya Investment Management LLC Cytosorbents Corp Transaction History

Voya Investment Management LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.76 - $3.22 $29,444 - $53,870	-16,730 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$4.05 - $8.11 $2,020 - $4,046	-499 Reduced 2.9%	16,730 $70,000
Q2 2021 Aug 16, 2021	SELL	$7.55 - $9.42 $11,793 - $14,714	-1,562 Reduced 8.31%	17,229 $130,000
Q1 2021 May 17, 2021	BUY	$8.23 - $11.48 $9,151 - $12,765	1,112 Added 6.29%	18,791 $163,000
Q4 2020 Feb 16, 2021	BUY	$7.65 - $8.98 $37,301 - $43,786	4,876 Added 38.08%	17,679 $141,000
Q3 2020 Nov 16, 2020	BUY	$7.37 - $11.54 $8,048 - $12,601	1,092 Added 9.32%	12,803 $102,000
Q2 2020 Aug 14, 2020	SELL	$6.28 - $10.59 $33,083 - $55,788	-5,268 Reduced 31.03%	11,711 $116,000
Q1 2020 May 15, 2020	SELL	$3.77 - $7.73 $11,091 - $22,741	-2,942 Reduced 14.77%	16,979 $131,000
Q4 2019 Feb 14, 2020	BUY	$3.61 - $5.22 $18,873 - $27,290	5,228 Added 35.58%	19,921 $77,000
Q2 2019 Aug 14, 2019	BUY	$5.92 - $7.78 $12,568 - $16,516	2,123 Added 16.89%	14,693 $97,000
Q4 2018 Feb 14, 2019	BUY	$7.05 - $12.64 $12,718 - $22,802	1,804 Added 16.76%	12,570 $102,000
Q3 2018 Nov 14, 2018	BUY	$10.95 - $14.8 $117,887 - $159,336	10,766 New	10,766 $139,000

17.1M

10.1K

500

Ticker CTSO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 43,577,400
Market Cap $40.5M
Description
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Voya Investment Management LLC with notifications on news.